Alexandros Kortsaris Selected Research

Mesna (Coenzyme M)

3/2009	Mesna protects splanchnic organs from oxidative stress induced by pneumoperitoneum.
2/2008	Prophylaxis with mesna prevents oxidative stress induced by ischemia reperfusion in the intestine via inhibition of nuclear factor-kappaB activation.
8/2006	Mesna protects intestinal mucosa from ischemia/reperfusion injury.
9/2004	Mesna ameliorates intestinal mucosa damage after ifosfamide administration in the rabbit at a dose-related manner.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexandros Kortsaris Research Topics

Disease

7	Neoplasms (Cancer) 04/2013 - 09/2004
4	Breast Neoplasms (Breast Cancer) 04/2013 - 11/2006
3	Ischemia 04/2009 - 08/2006
2	Myocardial Infarction 01/2006 - 07/2005
2	Acute Coronary Syndrome 01/2006 - 09/2005
2	Heart Failure 11/2005 - 07/2004
1	Glaucoma 11/2013
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 11/2013
1	Exfoliation Syndrome 11/2013
1	Urinary Tract Infections (Urinary Tract Infection) 07/2013
1	Hypertrophy 03/2013
1	Body Weight (Weight, Body) 01/2013
1	Seizures (Absence Seizure) 01/2013
1	Necrosis 03/2011
1	Endometrial Hyperplasia 03/2011
1	Ovarian Neoplasms (Ovarian Cancer) 03/2011
1	Fibroadenoma 03/2011
1	Fibrocystic Breast Disease (Chronic Cystic Mastitis) 03/2011
1	Female Genital Diseases 03/2011
1	Weight Loss (Weight Reduction) 03/2011
1	Pneumoperitoneum 03/2009
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2007
1	Lymphoma (Lymphomas) 01/2007
1	Burkitt Lymphoma (Burkitt's Lymphoma) 09/2006
1	Hemorrhagic Cystitis 08/2006
1	Reperfusion Injury 08/2006
1	Atherosclerotic Plaque (Atheroma) 01/2006
1	ST Elevation Myocardial Infarction 01/2006
1	Inflammation (Inflammations) 01/2006
1	Cardiomyopathies (Cardiomyopathy) 11/2005
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 11/2005
1	Latent Tuberculosis 10/2005
1	Infections 10/2005
1	Tuberculosis (Tuberculoses) 10/2005
1	Ventricular Remodeling 07/2005
1	Atherosclerosis 01/2005
1	Atrophy 09/2004
1	Mucositis 09/2004

Drug/Important Bio-Agent (IBA)

4	Matrix Metalloproteinases (MMPs)IBA 11/2013 - 07/2005
4	Mesna (Coenzyme M)FDA LinkGeneric 03/2009 - 09/2004
2	Metalloproteases (Metalloproteinases)IBA 11/2013 - 11/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2010 - 07/2004
2	NF-kappa B (NF-kB)IBA 04/2009 - 02/2008
2	salicylhydroxamic acid (SHAM)IBA 03/2009 - 02/2008
2	Rituximab (Mabthera)FDA Link 10/2007 - 01/2007
2	Sulfhydryl Compounds (Thiols)IBA 08/2006 - 09/2004
1	Tissue Inhibitor of Metalloproteinase-4IBA 11/2013
1	lipopolysaccharide-binding proteinIBA 07/2013
1	Hormones (Hormone)IBA 04/2013
1	NeuropeptidesIBA 04/2013
1	Peptides (Polypeptides)IBA 04/2013
1	His(5)-Trp(7)-Tyr(8)- LHRHIBA 04/2013
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 04/2013
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 03/2013
1	Silybin (Lagosa)IBA 03/2013
1	GhrelinIBA 01/2013
1	LeptinIBA 01/2013
1	Interleukin-6 (Interleukin 6)IBA 01/2013
1	Volatile Oils (Essential Oils)IBA 01/2013
1	Pentylenetetrazole (Metrazol)IBA 01/2013
1	SmokeIBA 01/2013
1	Amifostine (Ethyol)FDA LinkGeneric 03/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2011
1	Codon (Codons)IBA 07/2010
1	Tumor Biomarkers (Tumor Markers)IBA 07/2010
1	Corticotropin-Releasing HormoneIBA 04/2010
1	Docetaxel (Taxotere)FDA Link 01/2010
1	Capecitabine (Xeloda)FDA Link 01/2010
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2010
1	AntioxidantsIBA 03/2009
1	Valine (L-Valine)FDA Link 10/2007
1	Monoclonal AntibodiesIBA 01/2007
1	Fc gamma receptor IIAIBA 01/2007
1	Immunoglobulins (Immunoglobulin)IBA 01/2007
1	Immunoglobulin G (IgG)IBA 01/2007
1	Proteins (Proteins, Gene)FDA Link 11/2006
1	Syk KinaseIBA 11/2006
1	olomoucineIBA 09/2006
1	Oxidants (Oxidizing Agents)IBA 08/2006
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2006
1	Biomarkers (Surrogate Marker)IBA 01/2006
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 11/2005
1	Tissue Inhibitor of Metalloproteinase-1IBA 11/2005
1	Tuberculin (PPD)IBA 10/2005
1	Interleukin-18 (Interleukin 18)IBA 09/2005
1	Interleukin-10 (Interleukin 10)IBA 09/2005
1	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2005
1	CollagenIBA 07/2005
1	Anticardiolipin AntibodiesIBA 01/2005
1	Ifosfamide FDA LinkGeneric 09/2004
1	Alkylating AgentsIBA 09/2004
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2004
1	Biological ProductsIBA 07/2004
1	Type II Tumor Necrosis Factor ReceptorsIBA 07/2004
1	CytokinesIBA 07/2004

Therapy/Procedure

1	Therapeutics 04/2013
1	Thrombolytic Therapy 01/2006
1	Renal Dialysis (Hemodialysis) 10/2005
1	Drug Therapy (Chemotherapy) 09/2004